PROGRAM-CME CME CREDIT AVAILABLE
KEYNOTES
Keynote 1
Heike
Bischoff-
Ferrari
Zurich University,
Switzerland
Do-Health Trial
Keynote 2
Matteo
Cesari
Granda-Università
di Milano,
Italy
Intrinsic capacities
Keynote 3
Shalender Bhasin
Harvard Medical School,
Boston, USA
Effect of Protein Intake on Muscle Mass, Performance and Physical Function in Functionally-Limited Older Adults
Keynote 4
Bill
Evans
Duke University,
Durham,
USA
Biomarkers for sarcopenia
Keynote 5
Jeremy Walston
Johns Hopkins University,
Baltimore,
USA
Biomarker and biology of Frailty
CME COURSE
The Management of Frailty in Clinical Practice –
A Frailty PRIMER
ICFSR 2019 Course Friday, February 22nd, 2019 Miami Beach, Florida, USA
| 9:00 AM | 1. The Frailty Syndrome | Jeremy Walston, MD Johns Hopkins University, USA |
|---|---|---|
| 9:30 AM | 2. Consequences and Complications | Alfonso J. Cruz-Jentoft, MD, PhD Hospital U Ramón y Cajal, Spain |
| 10:00 AM | 3. The Role of Nutrition and Vitamin D | Heike A. Bischoff-Ferrari, MD, DrPH University Hospital Zurich |
| 10:30 AM | BREAK | |
| 11:00 AM | 4. The Role of Exercise & Physical Activity | Marco Pahor, MD Institute on Aging, U of Florida, USA |
| 11:30 AM | 5. The Role of Pharmacological Therapies | Matteo Cesari, MD, PhD U degli Studi di Milano, Italy |
| 12:00 PM | 6. Goals of Care and Palliative Care | Michael J. Mintzer, MD U of Miami and VA GRECC, USA |
| 12:30 AM | LUNCH | |
| 1:00 PM | 7. The Management of Sarcopenic Obesity | Roger Fielding, PhD Tufts University, USA |
| 2:00 PM | 8. Cognitive Frailty | Luis Miguel Gutiérrez, MD National Institute of Geriatrics, Mexico |
| 2:30 PM | 9. Prevention of Frailty | Bruno Vellas, MD Toulouse University Hospital, France |
| 3:00 PM | 10. Clinical Models | Jorge G. Ruiz, MD U of Miami and VA GRECC, USA |
PANELS DISCUSSIONS
Panel Discussion 1:
Panel discussion on definition for SarcopeniaPresentation: Alfonso Cruz Jentoft (Madrid - Spain)
Panel Discussion: Marco Pahor (Gainesville - USA), Yves Rolland (Toulouse-France), Matteo Cesari (Milan - Italy) , Roger Fielding (Boston - USA)
Panel Discussion 2:
Panel discussion on International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and ManagementPanel Discussion: John Morley (Saint Louis- USA), Elsa Dent (Adelaide - Australia)
SYMPOSIUMS
• Latest information on NIA’s research and related programs from other federal agencies
Rosaly Correa-de-Araujo, M.D., M.Sc., Ph.D.
National Institute on Aging, National Institutes of Health
U.S. Department of Health and Human Services
(Bethesda, USA)
• Selection of relevant outcomes in sarcopenia: a Discrete Choice Experiment
Chairpersons: Mickaël Hiligsmann, Charlotte Beaudart
Welcome and introduction: Jean-Yves Reginster
Identification and prioritization of important outcomes for patients in sarcopenia –
Charlotte Beaudart
Results from the cross-European Discrete Choice Experiment – Mickaël Hiligsmann
Discussion (Leader: Fanny Buckinx): Islene Araujo de Carvalho, Jürgen Bauer,
Charlotte Beaudart, Olivier Bruyère, Cyrus Cooper, Alfonso Cruz-Jentoft, Mickaël
Hiligsmann, Jean-Marc Kaufman, Jean-Yves Reginster, René Rizzoli.
Conclusion: Olivier Bruyère
• Osteosarcopenic obesity : enough evidence for a distinct entity?
Chairpersons: Islene Araujo de Carvalho, Roger Fielding.
Welcome and introduction: Jean-Yves Reginster
Osteosarcopenia obesity: Facts and evidence supporting a distinct entity
- Jürgen Bauer
Osteosarcopenic obesity: Lack of facts and evidence supporting a distinct entity –
Alfonso Cruz Jentoft
Discussion (Leader: René Rizzoli): Islene Araujo de Carvalho, Jürgen Bauer, Olivier Bruyère, Cyrus Cooper, Alfonso Cruz Jentoft, Roger Fielding, Jean- Marc Kaufman, Médéa Locquet, Jean-Yves Reginster.
Conclusion: Cyrus Cooper
Call for abstracts: Symposium/Oral communication/Poster: Submission deadline: November 5, 2018
